Results of whole-genome and transcriptome analysis identifies two genomic targets for potential treatment of adrenocortical cancer, a rare disease with limited therapeutic options.
The Birol Lab publishes ntEdit+Sealer, an alignment-free genome finishing protocol that corrects sequencing errors and fills gaps to produce highly accurate long-read genome assemblies.
A study from the Karsan lab concludes that predicting patient response to immunotherapy is not improved using tumour neoantigen counts from noncoding DNA.
Dr. Ryan Morin’s laboratory publishes a recent study assessing the genomic features of canine B-cell lymphoma and highlights differences in human B-cell lymphoma.
Part of a global effort to sequence, catalog, and characterize the genomes of life on Earth, the Canada BioGenome Project begins full scale sequencing.
Researchers from the GSC’s Marra Lab found the genetics and cellular makeup of 3D model systems to be highly reflective of the brain tumours from which they were derived.
BC Cancer researchers assess whole genome transcriptome analysis for its ability to identify genomic biomarkers and predict the tumour site or tissue of origin for various cancers.
The Gorski Lab shows that chloroquine induces the secretion of autophagy-related proteins, some of which are partitioned and packaged into distinct small vesicle populations.
